Enhanced Angiogenic and Cardiomyocyte Differentiation Capacity of Epigenetically Reprogrammed Mouse and Human Endothelial Progenitor Cells Augments their Efficacy for Ischemic Myocardial Repair

RATIONALE: While Bone-marrow endothelial progenitor cell based therapies (BM-EPC) improve the symptoms in patients with ischemic heart disease their limited plasticity and decreased function in patients with existing heart disease limits the full benefit of EPC therapy for cardiac regenerative medic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Thal, Melissa A., Krishnamurthy, Prasanna, Mackie, Alexander R., Hoxha, Eneda, Lambers, Erin, Verma, Suresh, Ramirez, Veronica, Qin, Gangjian, Losordo, Douglas W., Kishore, Raj
Formato: Artigo
Lenguaje:Inglês
Publicado: 2012
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3406600/
https://ncbi.nlm.nih.gov/pubmed/22589372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCRESAHA.112.270462
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares